Randall Kavalier
Psychiatry · West Des Moines, IANPI 1003884107
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,880 of the $15,335 with a category attached, or 64.4%. Corium, LLC accounts for 83.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $6,956 and has fallen 94.0% since, to $419 in 2025. Among psychiatry clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $56.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$13K
- Otsuka America Pharmaceutical, Inc.$495
- Lundbeck LLC$334
- Adlon Therapeutics L.p.$285
- Supernus Pharmaceuticals, Inc.$275
- Takeda Pharmaceuticals U.S.A., Inc.$263
- plus $920 from 12 others
What the payments were for
- Consulting fees$1,3159%
- Speaking & faculty fees$9,88064%
- Travel & lodging$250%
- Food & beverage$4,11527%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 103 | $12,763 |
| Otsuka America Pharmaceutical, Inc. | 29 | $495 |
| Lundbeck LLC | 17 | $334 |
| Adlon Therapeutics L.p. | 26 | $285 |
| Supernus Pharmaceuticals, Inc. | 22 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $263 |
| Ironshore Pharmaceuticals Inc. | 16 | $263 |
| Neos Therapeutics, LP | 13 | $201 |
| Tris Pharma Inc | 11 | $201 |
| Shire North American Group Inc | 3 | $61 |
| Vertical Pharmaceuticals, LLC | 3 | $48 |
| Eisai Inc. | 3 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Neuronetics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$11,818
How this compares
$15,335 in reported general payments places this provider in the 95th percentile of 245 psychiatry providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 55 | $9,295 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 39 | $9,163 |
| Chlorpromazine Hcl | 11 | $5,700 |
| Atomoxetine Hcl | 17 | $2,855 |
| Escitalopram Oxalate | 93 | $1,725 |
| Memantine Hcl | 37 | $1,311 |
| Clomipramine Hcl | 12 | $1,214 |
| Quetiapine Fumarate | 71 | $741 |
| Trazodone Hcl | 59 | $600 |
| Clonidine Hcl | 43 | $356 |
| Lorazepam | 15 | $178 |
| Lamotrigine | 24 | $162 |
| Benztropine Mesylate | 23 | $126 |
| Fluoxetine Hcl | 28 | $117 |
| Risperidone | 13 | $94 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in West Des Moines
- Cornelius GucfaWest Des Moines$1K
- Charles JennischUrbandale$949K
- Manmohan SinghDes Moines$408K
- Jimmy MascaroOttumwa$361K
- Alan WhittersCedar Rapids$170K
- Donald BlackIowa City$19K
- William CoryellIowa City$18K
- Dwight SchroederCedar Rapids$13K
- Rodney DeanSioux City$11K
- Peggy NopoulosIowa City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.